Stability of an extemporaneously compounded minoxidil oral suspension

被引:6
|
作者
Song, Yunmei [1 ]
Chin, Zen Whey [1 ]
Ellis, David [2 ]
Lwin, Ei Mon Phyo [1 ]
Turner, Sean [2 ]
Williams, Desmond [1 ]
Garg, Sanjay [3 ]
机构
[1] Univ South Australia, Sch Pharm & Med Sci, Ctr Pharmaceut Innovat & Dev, Adelaide, SA, Australia
[2] Womens & Childrens Hosp, Dept Pharm, Adelaide, SA, Australia
[3] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
关键词
chromatography; compounding; liquid; minoxidil; stability; storage; suspensions; HYPERTENSIVE CHILDREN; MEDICINES; THERAPY;
D O I
10.2146/ajhp160457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Results of a study to determine the stability of an extemporaneously compounded minoxidil oral suspension under various temperature and stress conditions are reported. Methods. Commercially available minoxidil tablets (10 mg) were crushed to a fine powder, and predetermined amounts of 2 suspending vehicles were added to produce a 1-mg/mL suspension, which was stored in glass bottles at room temperature (25 +/- 2 degrees C) or in a refrigerator (4 +/- 2 degrees C). To simulate daily patient use, 5 days weekly 1 bottle of the suspension was removed from refrigerated storage and shaken and 0.5 mL of the contents discarded. At each specified time point, samples were analyzed in duplicate (n = 6 for each test condition) using a validated high-performance liquid chromatography method. Samples were visually observed and their pH measured at each time point. Microbiological studies were performed on day 0 and at week 24. Results. The mean percentage of initial minoxidil concentration remaining in all refrigerated samples exceeded 90% throughout the 24-week study, with no change in appearance, pH, microbial activity, odor, or redispersibility. During storage at room temperature, the suspension exhibited a color change at week 4, with slight sedimentation after 6 weeks, although minoxidil recovery exceeded 90% for 10 weeks. Conclusion. An extemporaneously compounded minoxidil oral suspension was stable for 24 weeks when stored in a refrigerator. This suspension can be used for up to 3 weeks when stored at room temperature.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [1] Stability of amphotericin B in an extemporaneously compounded oral suspension
    Dentinger, PJ
    Swenson, CF
    Anaizi, NH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (11) : 1021 - 1024
  • [2] Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension
    Lwin, Ei Mon Phyo
    Ellis, David
    Song, Yunmei
    Turner, Sean
    Garg, Sanjay
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (02) : 155 - 156
  • [3] STABILITY OF FLECAINIDE ACETATE IN AN EXTEMPORANEOUSLY COMPOUNDED ORAL SUSPENSION
    WIEST, DB
    GARNER, SS
    PAGACZ, LR
    ZEIGLER, V
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (06): : 1467 - 1470
  • [4] STABILITY OF AN EXTEMPORANEOUSLY COMPOUNDED CISAPRIDE SUSPENSION
    HORN, JR
    ANDERSON, GD
    CLINICAL THERAPEUTICS, 1994, 16 (02) : 169 - 172
  • [5] Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia
    Lin, Yi-Shiu
    Lin, Shu-Chiao
    Hsieh, Ya-Ting
    Liu, Ling-Yu
    Lin, Chiu-Hsin
    Shen, Li-Jiuan
    Huang, Chih-Fen
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (06) : 324 - 328
  • [6] Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions
    Friciu, Mihaela
    Zaraa, Sarra
    Roullin, V. Gaelle
    Leclair, Gregoire
    PLOS ONE, 2016, 11 (10):
  • [7] Stability of gabapentin in extemporaneously compounded oral suspensions
    Friciu, Mihaela
    Roullin, V. Gaelle
    Leclair, Gregoire
    PLOS ONE, 2017, 12 (04):
  • [8] Stability of ganciclovir in extemporaneously compounded oral liquids
    Anaizi, NH
    Swenson, CF
    Dentinger, PJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (17) : 1738 - 1741
  • [9] Stability of flucytosine in an extemporaneously compounded oral liquid
    Wintermeyer, SM
    Nahata, MC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (04) : 407 - 409
  • [10] Stability of tacrolimus in an extemporaneously compounded oral liquid
    Jacobson, PA
    Johnson, CE
    West, NJ
    Foster, JA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (02) : 178 - 180